Martine Bot

1.5k citations

22 papers · 1.2k · h-index 16

Impact in

Immunology top 5%
- Atherosclerosis and Cardiovascular Diseases
- Mast cells and histamine
- Immune cells in cancer
Rheumatology top 5%
- GDF15 and Related Biomarkers

Papers in

Molecular Biology 10
- Sphingolipid Metabolism and Signaling 6
- Peroxisome Proliferator-Activated Receptors 1
Immunology 8
- Mast cells and histamine 3
- Atherosclerosis and Cardiovascular Diseases 3
- Immune cells in cancer 3

Co-authors: Erik A.L. Biessen (14 shared papers)Ilze Bot (14 shared papers)Theo J.C. van Berkel (13 shared papers)Saskia C.A. de Jager (8 shared papers)Johan Kuiper (8 shared papers)Theo van Berkel (2 shared papers)Horst Robenek (2 shared papers)Jerzy–Roch Nofer (4 shared papers)
Journals: Arteriosclerosis Thrombosis and Vascular Biology (4 papers)Scientific Reports (3 papers)Circulation (2 papers)Circulation Research (2 papers)Atherosclerosis (2 papers)
Partner nations: Netherlands Germany United States

In The Last Decade

Martine Bot

22 papers receiving 1.1k citations

Peers

Countries citing papers authored by Martine Bot

Since Specialization

Citations

This map shows the geographic impact of Martine Bot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martine Bot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martine Bot more than expected).

Fields of papers citing papers by Martine Bot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martine Bot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martine Bot. The network helps show where Martine Bot may publish in the future.

Co-authors

The 25 scholars most cited alongside Martine Bot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Martine Bot Line = papers co-authored together Martine Bot links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Apolipoprotein E Induces Antiinflammatory Phenotype in Macrophages Arteriosclerosis Thrombosis and Vascular Biology ·Daniel Baitsch, Hans H. Bock, Thomas Engel, Ralph Telgmann, Carsten Müller‐Tidow, Georg Varga, Martine Bot, Joachim Herz, Horst Robenek, Arnold von Eckardstein, Jerzy‐Roch Nofer	2011	263
2	FTY720, a Synthetic Sphingosine 1 Phosphate Analogue, Inhibits Development of Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice Circulation ·Jerzy–Roch Nofer, Martine Bot, Martin F. Brodde, (unknown), Paul Salm, Volker Brinkmann, Theo van Berkel, Gerd Assmann, Erik A.L. Biessen	2007	189
3	Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis The Journal of Experimental Medicine ·Saskia C.A. de Jager, Beatriz Bermúdez, Ilze Bot, Rory R. Koenen, Martine Bot, Annemieke Kavelaars, Vivian de Waard, Cobi J. Heijnen, Francisco J.G. Muriana, Christian Weber, Theo J.C. van Berkel, Johan Kuiper, Se‐Jin Lee, Rocı́o Abia, Erik A.L. Biessen	2011	167
4	Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammation Journal of Lipid Research ·Martine Bot, Saskia C.A. de Jager, Luke MacAleese, H. Maxime Lagraauw, Theo J.C. van Berkel, Paul H.A. Quax, Johan Kuiper, Ron M. A. Heeren, Erik A.L. Biessen, Ilze Bot	2013	60
5	Short Communication: The Neuropeptide Substance P Mediates Adventitial Mast Cell Activation and Induces Intraplaque Hemorrhage in Advanced Atherosclerosis Circulation Research ·Ilze Bot, Saskia C.A. de Jager, Martine Bot, Sandra H. van Heiningen, Paul de Groot, Roel W. Veldhuizen, Theo J.C. van Berkel, Jan H. von der Thüsen, Erik A.L. Biessen	2009	59
6	Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in ApoE−/− mice Cardiovascular Research ·Ilze Bot, Martine Bot, Sandra H. van Heiningen, Peter J. van Santbrink, Inge M. Lankhuizen, Peter Hartman, Sabine Gruener, Hans Hilpert, Theo J.C. van Berkel, Jürgen Fingerle, Erik A.L. Biessen	2010	56
7	Leukocyte-Specific CCL3 Deficiency Inhibits Atherosclerotic Lesion Development by Affecting Neutrophil Accumulation Arteriosclerosis Thrombosis and Vascular Biology ·Saskia C.A. de Jager, Ilze Bot, Adriaan O. Kraaijeveld, Suzanne J.A. Korporaal, Martine Bot, Peter J. van Santbrink, Theo J.C. van Berkel, Johan Kuiper, Erik A.L. Biessen	2013	56
8	Atherosclerotic Lesion Progression Changes Lysophosphatidic Acid Homeostasis to Favor its Accumulation American Journal Of Pathology ·Martine Bot, Ilze Bot, Rubén López‐Vales, Chris H.A. van de Lest, Jean Sébastien Saulnier‐Blache, J. Bernd Helms, Samuel David, Theo J.C. van Berkel, Erik A.L. Biessen	2010	55
9	Myocardin Regulates Vascular Response to Injury Through miR-24/-29a and Platelet-Derived Growth Factor Receptor-β Arteriosclerosis Thrombosis and Vascular Biology ·Amarnath Talasila, Haixiang Yu, Matthew Ackers‐Johnson, Martine Bot, Theo van Berkel, Martin R. Bennett, Ilze Bot, Sanjay Sinha	2013	44
10	Variations in Insulin Secretion in Carriers of the E23K Variant in the KIR6.2 Subunit of the ATP-Sensitive K+ Channel in the β-Cell Diabetes ·Leen M. ‘t Hart, Timon W. van Haeften, Joost Dekker, Martine Bot, Robert J. Heine, J. A. Maassen	2002	35
11	Vascular neuropeptide Y contributes to atherosclerotic plaque progression and perivascular mast cell activation Atherosclerosis ·H. Maxime Lagraauw, Marijke M. Westra, Martine Bot, Anouk Wezel, Peter J. van Santbrink, Gerard Pasterkamp, Erik A.L. Biessen, Johan Kuiper, Ilze Bot	2014	32
12	Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R−/−) mice Thrombosis and Haemostasis ·Francesco Potì, Martine Bot, Sara Costa, Valeria Bergonzini, Lynn W. Maines, Georg Varga, Hendrik Freise, Horst Robenek, Manuela Simoni, Jerzy–Roch Nofer	2012	25
13	Hematopoietic Sphingosine 1-Phosphate Lyase Deficiency Decreases Atherosclerotic Lesion Development in LDL-Receptor Deficient Mice PLoS ONE ·Martine Bot, Paul P. Van Veldhoven, Saskia C.A. de Jager, Jason L. Johnson, Niels Nijstad, Peter J. van Santbrink, Marijke M. Westra, Gerd Van der Hoeven, Marion J. Gijbels, Carsten Müller‐Tidow, Georg Varga, Uwe J.F. Tietge, Johan Kuiper, Theo J.C. van Berkel, Jerzy–Roch Nofer, Ilze Bot, Erik A.L. Biessen	2013	24
14	Adenosine A _2B Receptor Agonism Inhibits Neointimal Lesion Development After Arterial Injury in Apolipoprotein E–Deficient Mice Arteriosclerosis Thrombosis and Vascular Biology ·Ilze Bot, Henk de Vries, Suzanne J.A. Korporaal, Amanda C. Foks, Martine Bot, Jacobus van Veldhoven, Mariëtte N. D. ter Borg, Peter J. van Santbrink, Theo J.C. van Berkel, Johan Kuiper, Adriaan P. IJzerman	2012	22
15	Leukocyte TLR5 deficiency inhibits atherosclerosis by reduced macrophage recruitment and defective T-cell responsiveness Scientific Reports ·Guilielmus H.J.M. Ellenbroek, Gijs H.M. van Puijvelde, Adam A. Anas, Martine Bot, Miriam Asbach, Arjan H. Schoneveld, Peter J. van Santbrink, Amanda C. Foks, Leo Timmers, Pieter A. Doevendans, Gerard Pasterkamp, Imo E. Hoefer, Tom van der Poll, Johan Kuiper, Saskia C.A. de Jager	2017	18
16	Hematopoietic G‐protein‐coupled receptor kinase 2 deficiency decreases atherosclerotic lesion formation in LDL receptor‐knockout mice The FASEB Journal ·Jeroen J. T. Otten, Saskia C.A. de Jager, Annemieke Kavelaars, Tom Seijkens, Ilze Bot, Erwin Wijnands, Linda Beckers, Marijke M. Westra, Martine Bot, Matthias H. Busch, Beatriz Bermúdez, Theo J.C. van Berkel, Cobi J. Heijnen, Erik A.L. Biessen	2012	16
17	Macrophage ABCA2 deletion modulates intracellular cholesterol deposition, affects macrophage apoptosis, and decreases early atherosclerosis in LDL receptor knockout mice Atherosclerosis ·Laura Calpe‐Berdiel, Ying Zhao, Marjo de Graauw, Dan Ye, Peter J. van Santbrink, A. Mieke Mommaas, Amanda C. Foks, Martine Bot, Illiana Meurs, Johan Kuiper, Jody T. Mack, Miranda Van Eck, Kenneth D. Tew, Theo J.C. van Berkel	2012	13
18	Selective Modulation of Nuclear Factor of Activated T-Cell Function in Restenosis by a Potent Bipartite Peptide Inhibitor Circulation Research ·Haixiang Yu, Ilze Bot, Karen Sliedregt, Xingfu Xu, Martine Bot, Sandra H. van Heiningen, Gijs A. van der Marel, Martin R. Bennett, Herman S. Overkleeft, Theo J.C. van Berkel, Erik A.L. Biessen	2011	6
19	Low human and murine Mcl-1 expression leads to a pro-apoptotic plaque phenotype enriched in giant-cells Scientific Reports ·M Fontaine, Marijke M. Westra, Ilze Bot, Han Jin, Aimée J P M Franssen, Martine Bot, Saskia C.A. de Jager, Ivan Dzhagalov, You-Wen He, Bart J.M. van Vlijmen, Marion J. Gijbels, Chris Reutelingsperger, Theo J.C. van Berkel, Judith C. Sluimer, Lieve Temmerman, Erik A.L. Biessen	2019	6
20	Leukocyte Bim deficiency does not impact atherogenesis in ldlr −/− mice, despite a pronounced induction of autoimmune inflammation Scientific Reports ·Lieve Temmerman, Marijke M. Westra, Ilze Bot, Bart J.M. van Vlijmen, Niek van Bree, Martine Bot, Kim L. L. Habets, Tom G. Keulers, Johan van der Vlag, Thomas G. Cotter, Theo J.C. van Berkel, Erik A.L. Biessen	2017	5

About Martine Bot

Martine Bot is a scholar working on Molecular Biology, Immunology, Surgery, Cellular and Molecular Neuroscience and Oncology, having authored 22 papers that have together received 1.2k indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (6 papers), Mast cells and histamine (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Cholesterol and Lipid Metabolism (3 papers), Immune cells in cancer (3 papers), Chemokine receptors and signaling (2 papers), Cell Adhesion Molecules Research (2 papers) and Peroxisome Proliferator-Activated Receptors (1 paper). The work is most often cited by research in Immunology (399 citations), Rheumatology (167 citations), Immunology and Allergy (42 citations), Physiology (33 citations) and Molecular Biology (487 citations). Martine Bot has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Erik A.L. Biessen, Ilze Bot, Theo J.C. van Berkel, Saskia C.A. de Jager, Johan Kuiper, Theo van Berkel, Horst Robenek, Jerzy–Roch Nofer, Carsten Müller‐Tidow and Georg Varga. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, Scientific Reports, Circulation, Circulation Research and Atherosclerosis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Martine Bot

Impact in

Papers in i

In The Last Decade

Martine Bot

Peers

Countries citing papers authored by Martine Bot

Fields of papers citing papers by Martine Bot

All Works

About Martine Bot

Explore authors with similar magnitude of impact

Papers in